Sanjivani Paranteral Ltd

Sanjivani Paranteral Ltd

₹ 178 5.55%
19 Apr - close price
About

Incorporated in 1994, Sanjivani Paranteral
Ltd does manufacturing and export of pharmaceutical products[1]

Key Points

Business Overview:
Sanjivani Paranteral Ltd is a pharmaceutical company headquartered in Mumbai. It specializes in manufacturing and distribution of high-quality parenteral and oral solid products. It caters to major therapeutic areas encompassing CNS, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.[1]

  • Market Cap 208 Cr.
  • Current Price 178
  • High / Low 188 / 49.2
  • Stock P/E 35.2
  • Book Value 0.19
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is expected to give good quarter
  • Debtor days have improved from 57.6 to 17.5 days.

Cons

  • Stock is trading at 936 times its book value
  • Promoter holding has decreased over last quarter: -4.67%
  • Promoter holding is low: 27.7%
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
4.78 7.20 8.08 9.72 7.60 5.21 9.92 8.33 9.12 8.12 12.58 14.00 14.96
4.29 5.74 7.32 8.40 5.65 3.52 7.77 7.20 8.20 6.69 10.57 11.88 12.99
Operating Profit 0.49 1.46 0.76 1.32 1.95 1.69 2.15 1.13 0.92 1.43 2.01 2.12 1.97
OPM % 10.25% 20.28% 9.41% 13.58% 25.66% 32.44% 21.67% 13.57% 10.09% 17.61% 15.98% 15.14% 13.17%
0.01 0.18 0.07 0.08 0.03 0.06 0.12 0.17 0.31 -0.04 0.06 0.15 0.25
Interest 0.03 0.03 0.03 0.04 0.06 0.08 0.07 0.07 0.05 0.16 0.04 0.05 0.08
Depreciation 0.21 0.23 0.18 0.25 0.22 0.23 0.22 0.22 0.23 0.23 0.23 0.23 0.24
Profit before tax 0.26 1.38 0.62 1.11 1.70 1.44 1.98 1.01 0.95 1.00 1.80 1.99 1.90
Tax % 0.00% -0.72% 0.00% 0.00% 0.00% 2.08% 9.60% 23.76% 0.00% 0.00% 13.89% 14.07% 13.16%
0.25 1.39 0.63 1.11 1.70 1.41 1.80 0.77 0.95 1.00 1.55 1.71 1.65
EPS in Rs 0.42 1.64 0.74 1.11 1.70 1.41 1.80 0.77 0.95 1.00 1.55 1.71 1.65
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
150.35 151.70 158.50 133.03 115.31 32.53 17.96 25.09 16.29 25.09 30.59 41.45 49.66
138.89 141.11 148.93 127.71 120.84 55.81 70.17 26.85 16.62 22.95 24.86 35.80 42.13
Operating Profit 11.46 10.59 9.57 5.32 -5.53 -23.28 -52.21 -1.76 -0.33 2.14 5.73 5.65 7.53
OPM % 7.62% 6.98% 6.04% 4.00% -4.80% -71.56% -290.70% -7.01% -2.03% 8.53% 18.73% 13.63% 15.16%
1.84 2.12 2.51 1.24 0.73 2.85 0.48 0.96 0.25 0.26 0.24 0.54 0.42
Interest 9.08 7.93 8.09 7.92 8.81 4.79 0.45 0.33 0.66 0.13 0.21 0.36 0.33
Depreciation 0.95 0.99 0.95 1.41 1.36 1.20 1.19 1.17 1.07 0.86 0.88 0.89 0.93
Profit before tax 3.27 3.79 3.04 -2.77 -14.97 -26.42 -53.37 -2.30 -1.81 1.41 4.88 4.94 6.69
Tax % 17.74% 36.15% 47.37% 13.00% 2.20% 0.72% 0.60% 10.00% 5.52% -0.71% 0.61% 8.70%
2.69 2.43 1.59 -2.41 -14.64 -26.22 -53.06 -2.07 -1.71 1.42 4.85 4.51 5.91
EPS in Rs 4.56 4.12 2.70 -4.09 -24.82 -44.45 -89.96 -3.51 -2.90 1.67 4.85 4.51 5.91
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -12%
5 Years: 18%
3 Years: 37%
TTM: 52%
Compounded Profit Growth
10 Years: 6%
5 Years: 16%
3 Years: 67%
TTM: 20%
Stock Price CAGR
10 Years: 27%
5 Years: 121%
3 Years: 153%
1 Year: 252%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 5.90 5.90 5.90 5.90 5.90 5.90 5.90 5.90 5.90 8.50 10.00 10.00 10.00
Reserves 25.08 27.52 29.11 26.24 11.60 -14.62 -58.72 -53.10 -54.81 -53.39 -17.58 -13.07 -9.81
58.22 57.39 56.90 57.06 62.20 59.89 48.23 48.09 48.91 46.05 6.00 2.49 0.69
20.08 22.35 25.46 24.48 13.42 9.15 29.61 17.09 15.66 18.11 19.87 21.59 23.45
Total Liabilities 109.28 113.16 117.37 113.68 93.12 60.32 25.02 17.98 15.66 19.27 18.29 21.01 24.33
23.25 23.86 24.24 13.52 12.69 11.19 10.17 8.99 8.04 7.62 7.42 7.57 9.78
CWIP 0.00 0.07 0.07 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05
85.98 89.18 93.01 100.10 80.38 49.08 14.80 8.94 7.57 11.60 10.82 13.39 14.50
Total Assets 109.28 113.16 117.37 113.68 93.12 60.32 25.02 17.98 15.66 19.27 18.29 21.01 24.33

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
9.21 7.36 8.77 -1.20 0.45 9.57 3.05 2.48 -0.17 0.58 8.52 4.68
-8.45 -1.20 -1.32 8.68 -0.50 0.30 -0.20 0.02 -0.12 -0.42 -0.67 -0.99
-0.98 -5.97 -7.57 -7.30 -0.51 -10.05 -2.83 -2.30 0.33 -0.26 -7.68 -3.73
Net Cash Flow -0.22 0.19 -0.12 0.18 -0.57 -0.18 0.03 0.20 0.03 -0.09 0.17 -0.04

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 149.18 142.01 149.34 184.24 151.59 358.38 107.71 75.79 23.97 96.45 58.71 17.52
Inventory Days 45.80 50.08 54.73 68.59 65.35 127.41 34.08 13.56 66.80 22.43 51.89 105.21
Days Payable 41.96 43.74 48.78 37.50 19.51 42.51 169.13 292.82 434.62 261.00 339.20 269.82
Cash Conversion Cycle 153.02 148.35 155.29 215.34 197.43 443.28 -27.33 -203.47 -343.84 -142.12 -228.61 -147.08
Working Capital Days 148.40 150.50 144.80 198.43 180.87 368.14 -460.72 -181.99 -342.37 -174.86 -134.24 -114.03
ROCE % 14.55% 13.02% 12.18% 5.95% -7.31% -35.52% -227.18% -258.43% 265.52%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
24.63% 19.85% 27.35% 27.35% 27.35% 27.35% 27.35% 29.88% 31.70% 32.34% 32.34% 27.67%
11.77% 16.50% 16.50% 16.50% 16.50% 16.50% 16.50% 14.23% 11.89% 8.16% 6.01% 9.71%
63.60% 63.65% 56.14% 56.14% 56.14% 56.14% 56.14% 55.89% 56.40% 59.51% 61.65% 62.62%
No. of Shareholders 4,9114,8295,0044,9744,8484,8264,8454,8874,7584,5004,5004,911

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls